[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Pediatric Neuroblastoma Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

October 2018 | 118 pages | ID: G2891BCD920GEN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SCOPE OF THE REPORT:

In terms of therapy type, the market has been classified into immunotherapy, chemotherapy, and others. The chemotherapy segment held leading market share in 2017.
Based on distribution channel, the global pediatric neuroblastoma treatment market has been categorized into hospital pharmacies and retail pharmacies & drug stores. The hospital pharmacies segment dominated the market in 2017 and is expected to retain its leadership position in terms of market share during the forecast period.
The global Pediatric Neuroblastoma Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Pediatric Neuroblastoma Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Pediatric Neuroblastoma Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Pediatric Neuroblastoma Treatment market by product type and applications/end industries.
Market Segment by Companies, this report covers
  • United Therapeutics
  • Apeiron Biologics
  • Pfizer
  • Bayer
  • Baxter
  • Cellectar Biosciences
  • MacroGenics
Market Segment by Regions, regional analysis covers
  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, UK, Russia and Italy)
  • Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  • South America (Brazil, Argentina, Colombia)
  • Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
  • Immunotherapy
  • Chemotherapy
  • Others
Market Segment by Applications, can be divided into
  • Hospitals
  • Clinics
  • Others
1 PEDIATRIC NEUROBLASTOMA TREATMENT MARKET OVERVIEW

1.1 Product Overview and Scope of Pediatric Neuroblastoma Treatment
1.2 Classification of Pediatric Neuroblastoma Treatment by Types
  1.2.1 Global Pediatric Neuroblastoma Treatment Revenue Comparison by Types (2017-2023)
  1.2.2 Global Pediatric Neuroblastoma Treatment Revenue Market Share by Types in 2017
  1.2.3 Immunotherapy
  1.2.4 Chemotherapy
  1.2.5 Others
1.3 Global Pediatric Neuroblastoma Treatment Market by Application
  1.3.1 Global Pediatric Neuroblastoma Treatment Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospitals
  1.3.3 Clinics
  1.3.4 Others
1.4 Global Pediatric Neuroblastoma Treatment Market by Regions
  1.4.1 Global Pediatric Neuroblastoma Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Pediatric Neuroblastoma Treatment Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Pediatric Neuroblastoma Treatment Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Pediatric Neuroblastoma Treatment Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Pediatric Neuroblastoma Treatment Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Pediatric Neuroblastoma Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Pediatric Neuroblastoma Treatment (2013-2023)

2 MANUFACTURERS PROFILES

2.1 United Therapeutics
  2.1.1 Business Overview
  2.1.2 Pediatric Neuroblastoma Treatment Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 United Therapeutics Pediatric Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 Apeiron Biologics
  2.2.1 Business Overview
  2.2.2 Pediatric Neuroblastoma Treatment Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Apeiron Biologics Pediatric Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 Pfizer
  2.3.1 Business Overview
  2.3.2 Pediatric Neuroblastoma Treatment Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Pfizer Pediatric Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 Bayer
  2.4.1 Business Overview
  2.4.2 Pediatric Neuroblastoma Treatment Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Bayer Pediatric Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.5 Baxter
  2.5.1 Business Overview
  2.5.2 Pediatric Neuroblastoma Treatment Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Baxter Pediatric Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.6 Cellectar Biosciences
  2.6.1 Business Overview
  2.6.2 Pediatric Neuroblastoma Treatment Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Cellectar Biosciences Pediatric Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.7 MacroGenics
  2.7.1 Business Overview
  2.7.2 Pediatric Neuroblastoma Treatment Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 MacroGenics Pediatric Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL PEDIATRIC NEUROBLASTOMA TREATMENT MARKET COMPETITION, BY PLAYERS

3.1 Global Pediatric Neuroblastoma Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Pediatric Neuroblastoma Treatment Players Market Share
  3.2.2 Top 10 Pediatric Neuroblastoma Treatment Players Market Share
3.3 Market Competition Trend

4 GLOBAL PEDIATRIC NEUROBLASTOMA TREATMENT MARKET SIZE BY REGIONS

4.1 Global Pediatric Neuroblastoma Treatment Revenue and Market Share by Regions
4.2 North America Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA PEDIATRIC NEUROBLASTOMA TREATMENT REVENUE BY COUNTRIES

5.1 North America Pediatric Neuroblastoma Treatment Revenue by Countries (2013-2018)
5.2 USA Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)

6 EUROPE PEDIATRIC NEUROBLASTOMA TREATMENT REVENUE BY COUNTRIES

6.1 Europe Pediatric Neuroblastoma Treatment Revenue by Countries (2013-2018)
6.2 Germany Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
6.4 France Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC PEDIATRIC NEUROBLASTOMA TREATMENT REVENUE BY COUNTRIES

7.1 Asia-Pacific Pediatric Neuroblastoma Treatment Revenue by Countries (2013-2018)
7.2 China Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
7.5 India Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA PEDIATRIC NEUROBLASTOMA TREATMENT REVENUE BY COUNTRIES

8.1 South America Pediatric Neuroblastoma Treatment Revenue by Countries (2013-2018)
8.2 Brazil Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE PEDIATRIC NEUROBLASTOMA TREATMENT BY COUNTRIES

9.1 Middle East and Africa Pediatric Neuroblastoma Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)

10 GLOBAL PEDIATRIC NEUROBLASTOMA TREATMENT MARKET SEGMENT BY TYPE

10.1 Global Pediatric Neuroblastoma Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Pediatric Neuroblastoma Treatment Market Forecast by Type (2018-2023)
10.3 Immunotherapy Revenue Growth Rate (2013-2023)
10.4 Chemotherapy Revenue Growth Rate (2013-2023)
10.5 Others Revenue Growth Rate (2013-2023)

11 GLOBAL PEDIATRIC NEUROBLASTOMA TREATMENT MARKET SEGMENT BY APPLICATION

11.1 Global Pediatric Neuroblastoma Treatment Revenue Market Share by Application (2013-2018)
11.2 Pediatric Neuroblastoma Treatment Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
11.5 Others Revenue Growth (2013-2018)

12 GLOBAL PEDIATRIC NEUROBLASTOMA TREATMENT MARKET SIZE FORECAST (2018-2023)

12.1 Global Pediatric Neuroblastoma Treatment Market Size Forecast (2018-2023)
12.2 Global Pediatric Neuroblastoma Treatment Market Forecast by Regions (2018-2023)
12.3 North America Pediatric Neuroblastoma Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Pediatric Neuroblastoma Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Pediatric Neuroblastoma Treatment Revenue Market Forecast (2018-2023)
12.6 South America Pediatric Neuroblastoma Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Pediatric Neuroblastoma Treatment Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source



LIST OF TABLES AND FIGURES

Figure Pediatric Neuroblastoma Treatment Picture
Table Product Specifications of Pediatric Neuroblastoma Treatment
Table Global Pediatric Neuroblastoma Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Pediatric Neuroblastoma Treatment Revenue Market Share by Types in 2017
Figure Immunotherapy Picture
Figure Chemotherapy Picture
Figure Others Picture
Table Global Pediatric Neuroblastoma Treatment Revenue (Million USD) by Application (2013-2023)
Figure Pediatric Neuroblastoma Treatment Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Clinics Picture
Figure Others Picture
Table Global Market Pediatric Neuroblastoma Treatment Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Pediatric Neuroblastoma Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Pediatric Neuroblastoma Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Pediatric Neuroblastoma Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Pediatric Neuroblastoma Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Pediatric Neuroblastoma Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Pediatric Neuroblastoma Treatment Revenue (Million USD) and Growth Rate (2013-2023)
Table United Therapeutics Basic Information, Manufacturing Base and Competitors
Table United Therapeutics Pediatric Neuroblastoma Treatment Type and Applications
Table United Therapeutics Pediatric Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Apeiron Biologics Basic Information, Manufacturing Base and Competitors
Table Apeiron Biologics Pediatric Neuroblastoma Treatment Type and Applications
Table Apeiron Biologics Pediatric Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Pediatric Neuroblastoma Treatment Type and Applications
Table Pfizer Pediatric Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Pediatric Neuroblastoma Treatment Type and Applications
Table Bayer Pediatric Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Baxter Basic Information, Manufacturing Base and Competitors
Table Baxter Pediatric Neuroblastoma Treatment Type and Applications
Table Baxter Pediatric Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Cellectar Biosciences Basic Information, Manufacturing Base and Competitors
Table Cellectar Biosciences Pediatric Neuroblastoma Treatment Type and Applications
Table Cellectar Biosciences Pediatric Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table MacroGenics Basic Information, Manufacturing Base and Competitors
Table MacroGenics Pediatric Neuroblastoma Treatment Type and Applications
Table MacroGenics Pediatric Neuroblastoma Treatment Revenue, Gross Margin and Market Share (2016-2017)
Table Global Pediatric Neuroblastoma Treatment Revenue (Million USD) by Players (2013-2018)
Table Global Pediatric Neuroblastoma Treatment Revenue Share by Players (2013-2018)
Figure Global Pediatric Neuroblastoma Treatment Revenue Share by Players in 2016
Figure Global Pediatric Neuroblastoma Treatment Revenue Share by Players in 2017
Figure Global Top 5 Players Pediatric Neuroblastoma Treatment Revenue Market Share in 2017
Figure Global Top 10 Players Pediatric Neuroblastoma Treatment Revenue Market Share in 2017
Figure Global Pediatric Neuroblastoma Treatment Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Pediatric Neuroblastoma Treatment Revenue (Million USD) by Regions (2013-2018)
Table Global Pediatric Neuroblastoma Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Pediatric Neuroblastoma Treatment Revenue Market Share by Regions (2013-2018)
Figure Global Pediatric Neuroblastoma Treatment Revenue Market Share by Regions in 2017
Figure North America Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure Europe Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure South America Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
Table North America Pediatric Neuroblastoma Treatment Revenue by Countries (2013-2018)
Table North America Pediatric Neuroblastoma Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Pediatric Neuroblastoma Treatment Revenue Market Share by Countries (2013-2018)
Figure North America Pediatric Neuroblastoma Treatment Revenue Market Share by Countries in 2017
Figure USA Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure Canada Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure Mexico Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
Table Europe Pediatric Neuroblastoma Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Europe Pediatric Neuroblastoma Treatment Revenue Market Share by Countries (2013-2018)
Figure Europe Pediatric Neuroblastoma Treatment Revenue Market Share by Countries in 2017
Figure Germany Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure UK Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure France Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure Russia Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure Italy Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Pediatric Neuroblastoma Treatment Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Pediatric Neuroblastoma Treatment Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Pediatric Neuroblastoma Treatment Revenue Market Share by Countries in 2017
Figure China Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure Japan Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure Korea Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure India Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
Table South America Pediatric Neuroblastoma Treatment Revenue by Countries (2013-2018)
Table South America Pediatric Neuroblastoma Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Pediatric Neuroblastoma Treatment Revenue Market Share by Countries (2013-2018)
Figure South America Pediatric Neuroblastoma Treatment Revenue Market Share by Countries in 2017
Figure Brazil Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure Argentina Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure Colombia Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Pediatric Neuroblastoma Treatment Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Pediatric Neuroblastoma Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Pediatric Neuroblastoma Treatment Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Pediatric Neuroblastoma Treatment Revenue Market Share by Countries in 2017
Figure Saudi Arabia Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure UAE Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure Egypt Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure Nigeria Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
Figure South Africa Pediatric Neuroblastoma Treatment Revenue and Growth Rate (2013-2018)
Table Global Pediatric Neuroblastoma Treatment Revenue (Million USD) by Type (2013-2018)
Table Global Pediatric Neuroblastoma Treatment Revenue Share by Type (2013-2018)
Figure Global Pediatric Neuroblastoma Treatment Revenue Share by Type (2013-2018)
Figure Global Pediatric Neuroblastoma Treatment Revenue Share by Type in 2017
Table Global Pediatric Neuroblastoma Treatment Revenue Forecast by Type (2018-2023)
Figure Global Pediatric Neuroblastoma Treatment Market Share Forecast by Type (2018-2023)
Figure Global Immunotherapy Revenue Growth Rate (2013-2018)
Figure Global Chemotherapy Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Table Global Pediatric Neuroblastoma Treatment Revenue by Application (2013-2018)
Table Global Pediatric Neuroblastoma Treatment Revenue Share by Application (2013-2018)
Figure Global Pediatric Neuroblastoma Treatment Revenue Share by Application (2013-2018)
Figure Global Pediatric Neuroblastoma Treatment Revenue Share by Application in 2017
Table Global Pediatric Neuroblastoma Treatment Revenue Forecast by Application (2018-2023)
Figure Global Pediatric Neuroblastoma Treatment Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Clinics Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Figure Global Pediatric Neuroblastoma Treatment Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Pediatric Neuroblastoma Treatment Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Pediatric Neuroblastoma Treatment Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Pediatric Neuroblastoma Treatment Revenue Market Forecast (2018-2023)
Figure Europe Pediatric Neuroblastoma Treatment Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Pediatric Neuroblastoma Treatment Revenue Market Forecast (2018-2023)
Figure South America Pediatric Neuroblastoma Treatment Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Pediatric Neuroblastoma Treatment Revenue Market Forecast (2018-2023)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories